Newport, DE – Avkin’s newest device, the Avline, brings central line simulation to life. Central line care is vital to the continued health and recovery of patients suffering from cancer, infection, or other serious illness. These lines allow for chemotherapy and nutrition without needing to continuously start new IV lines.
With the Avline wearable device, learners will have the ability to practice a range of procedures including CVC infusion and care as well as port infusion, access, and de-access. Haptic sensors cue the patient to respond when a needle is inserted into the port and pressure is put on the surgical site. With realistic heart sounds, the learner can do a full assessment before providing care. The Avline provides the highest fidelity patient experience for central venous education, and when paired with Avkin simulations, allows learners to truly focus on patient-centered care.
The Avline is just one of several Avkin devices and services aimed at creating lifelike high-fidelity simulations for healthcare learners of all levels. For more information, or to see a video demonstration, please visit https://avkin.com/avline-infusion-simulator/.
MEDIA CONTACT ONLY:
Garret Walton – [email protected]
Founded in 2016 as a spinout company from the University of Delaware, Avkin was created by Amy Cowperthwait, a nursing simulationist. Frustrated with traditional simulation marketing, she founded Avkin to create high-fidelity wearables and educational services. These are designed to bring healthcare simulations to life thereby maximizing educational outcomes for learners of all skill levels. We currently offer six wearable devices, as well as training for faculty, staff and actors portraying patients. Avkin’s unique products and philosophy have earned it national attention, with awards including industry leader INACSL’s Haden VanGuard Lectureship Award, Best University Startup by the National Council of Entrepreneurial Tech Transfer, and even an appearance with Damon John on the Dr. Oz Show.